DK100281A - Fremgangsmaade til fremstilling af imidazolderivater - Google Patents

Fremgangsmaade til fremstilling af imidazolderivater

Info

Publication number
DK100281A
DK100281A DK100281A DK100281A DK100281A DK 100281 A DK100281 A DK 100281A DK 100281 A DK100281 A DK 100281A DK 100281 A DK100281 A DK 100281A DK 100281 A DK100281 A DK 100281A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
imidazold
derivatives
imidazold derivatives
Prior art date
Application number
DK100281A
Other languages
Danish (da)
English (en)
Inventor
P E Cross
R P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK100281A publication Critical patent/DK100281A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK100281A 1980-03-08 1981-03-05 Fremgangsmaade til fremstilling af imidazolderivater DK100281A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8008084 1980-03-08

Publications (1)

Publication Number Publication Date
DK100281A true DK100281A (da) 1981-09-09

Family

ID=10511980

Family Applications (1)

Application Number Title Priority Date Filing Date
DK100281A DK100281A (da) 1980-03-08 1981-03-05 Fremgangsmaade til fremstilling af imidazolderivater

Country Status (6)

Country Link
US (1) US4350696A (cs)
EP (1) EP0035863B1 (cs)
JP (1) JPS56139483A (cs)
DE (1) DE3161260D1 (cs)
DK (1) DK100281A (cs)
GR (1) GR74485B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57169452A (en) * 1981-04-14 1982-10-19 Teikoku Hormone Mfg Co Ltd Novel phenoxyalkylamide derivative
US4600431A (en) * 1984-09-17 1986-07-15 Stauffer Chemical Company N-pyrimidyl aryloxyphenoxy alkanoic acid amides and methods of use
US7700583B2 (en) * 2003-04-11 2010-04-20 High Point Pharmaceuticals, Llc 11β-hydroxysteroid dehydrogenase type 1 active compounds
EP1615698B1 (en) * 2003-04-11 2010-09-29 High Point Pharmaceuticals, LLC New amide derivatives and pharmaceutical use thereof
US8138342B2 (en) * 2004-10-12 2012-03-20 High Point Pharmacueticals, LLC 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds
CA2627306A1 (en) * 2005-11-01 2007-05-10 Transtech Pharma, Inc. Pharmaceutical use of substituted amides
US8053431B2 (en) * 2005-11-01 2011-11-08 High Point Pharmaceuticals, Llc Pharmaceutical use of substituted amides
CA2646588A1 (en) * 2006-03-21 2007-09-27 High Point Pharmaceuticals, Llc Adamantane derivatives for the treatment of the metabolic syndrome
KR20090014347A (ko) 2006-04-07 2009-02-10 하이 포인트 파마슈티칼스, 엘엘씨 11β-히드록시스테로이드 탈수소효소 타입 1 활성 화합물
US20090306048A1 (en) * 2006-06-16 2009-12-10 John Paul Kilburn Pharmaceutical use of substituted piperidine carboxamides
EP1878721A1 (en) * 2006-07-13 2008-01-16 Novo Nordisk A/S 4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
WO2008006702A1 (en) * 2006-07-13 2008-01-17 High Point Pharmaceuticals, Llc. 11beta-hydroxysteroid dehydrogenase type 1 active compounds
WO2008101907A2 (en) * 2007-02-23 2008-08-28 High Point Pharmaceuticals, Llc N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
JP2010519239A (ja) * 2007-02-23 2010-06-03 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー １１−ベータ−ヒドロキシステロイドデヒドロゲナーゼの阻害因子としてのｎ−アドマンチルベンザミド
BRPI0806847A2 (pt) * 2007-02-23 2014-04-29 High Point Pharmaceuticals Llc N-adamantil benzamidas como inibidores de 11-beta-hidroxiesteróide desidrogenase
EP2125704A1 (en) * 2007-02-23 2009-12-02 High Point Pharmaceuticals, LLC N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
MX2009009623A (es) * 2007-03-09 2009-09-21 High Point Pharmaceuticals Llc Inidol y bencimidazol amidas como inhibidores de la dehidrogenasa hidroxi-esteroide.
JP2010522766A (ja) * 2007-03-28 2010-07-08 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー １１ベータ−ｈｓｄ１活性化合物
CA2683852A1 (en) * 2007-04-11 2008-10-23 High Point Pharmaceuticals, Llc Novel compounds
CA2685036A1 (en) * 2007-04-24 2008-11-06 High Point Pharmaceuticals, Llc Pharmaceutical use of substituted amides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4941434B1 (cs) * 1970-09-24 1974-11-08
US3862163A (en) * 1971-10-14 1975-01-21 Schering Ag Phenoxycarboxylic acid amides
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
GB2028317B (en) * 1978-08-15 1982-11-10 Pfizer Ltd 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors
JPS5951943B2 (ja) 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
DK471479A (da) 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
GB2041363B (en) 1979-01-19 1982-10-06 Pfizer Ltd N-benzyl-imidazoles

Also Published As

Publication number Publication date
US4350696A (en) 1982-09-21
EP0035863A1 (en) 1981-09-16
GR74485B (cs) 1984-06-28
JPS56139483A (en) 1981-10-30
DE3161260D1 (en) 1983-12-01
EP0035863B1 (en) 1983-10-26

Similar Documents

Publication Publication Date Title
DK534481A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK99781A (da) Fremgangsmaade til fremstilling af carboxtyrilderivater
DK2281A (da) Fremgangsmaade til fremstilling af tiazolinderivater
DK300981A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK157876C (da) Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
DK112582A (da) Fremgangsmaade til fremstilling af triazolonderivater
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK162524C (da) Analogifremgangsmaade til fremstilling af 5-alkylthio-tetrazolderivater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK352082A (da) Fremgangsmaade til fremstilling af ergopeptinderivater
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK564781A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK554581A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK565281A (da) Fremgangsmaade til fremstilling af quinolon-derivater
DK364481A (da) Fremgangsmaade til fremstilling af caprylolactamer
DK151956C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK85281A (da) Fremgangsmaade til fremstilling af phenoxyderivater
DK424781A (da) Fremgangsmaade til fremstilling af quinolonderivater
DK448981A (da) Fremgangsmaade til fremstilling af 4-chinolinmethanderivater
DK296281A (da) Fremgangsmaade til fremstilling af aminocyklopentanonamider
DK70482A (da) Fremgangsmaade til fremstilling af diazolderivater
DK551481A (da) Fremgangsmaade til fremstilling af triazolderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment